PRCT

PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.

PROCEPT BioRobotics Corporation (PRCT) is rated C+ (2.8/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (B); its weakest is Momentum (C+).

Quantitative Factor Evaluation • Updated

Overall Rating
2.8 / 5.0
C+
Value
B-
Factor Score 3.0 / 5.0
Growth
C+
Factor Score 2.6 / 5.0
Profitability
B
Factor Score 3.4 / 5.0
Momentum
C+
Factor Score 2.5 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -19.4
EV / EBITDA -10.8
Rev Growth YoY 18.0%
Gross Margin 63.7%
Price Return 3M 12.8%
Price Return 12M -22.6%
Catalyst Signal 0.00
Market Cap $1.4B
TTM Revenue $352.3M
Price / Sales 3.9
ROE -32.4%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-14 B- (3.0) C+ (2.6) B (3.4) C+ (2.5) C+ (2.6) C+ (2.8)
2026-11-07 B- (3.0) C+ (2.7) B (3.4) C (2.3) C+ (2.7) C+ (2.8)
2026-10-31 B- (3.0) C+ (2.7) B (3.3) C (2.3) F (0.0) C (2.3)
2026-10-24 B- (3.0) C+ (2.6) B (3.3) C (2.3) F (0.0) C (2.3)
2026-10-17 B- (3.0) C+ (2.6) B (3.3) C- (2.1) F (0.0) C (2.2)
Page 1 of 8
…